世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038545

ゲノム編集技術市場レポート2024-2034

Visiongain

Genome Editing Technologies Market Report 2024-2034

発刊日 2024/05/31

言語英語

体裁PDF/311ページ

ライセンス/価格311ページ

0000038545

Single - 1 Year License
(Team License - Up to 6 Users) - 1 Year License
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数6人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

技術別 (CRISPR、TALEN、ZFN、メガヌクレアーゼ、その他)、用途別 (遺伝子工学 (細胞株工学、動物遺伝子工学、植物遺伝子工学、その他)、創薬・開発、診断応用別)、エンドユーザー別 (バイオテクノロジー企業、製薬会社、学術・政府研究機関、その他)、地域別・主要国内市場分析、主要企業の分析、COVID-19の影響と回復パターン解析

新興国が産業の成長を後押しすると予測
中国、インド、南アフリカ、メキシコ、シンガポール、ブラジル、ロシア、韓国、インドネシア、トルコなどの新興経済国は、ゲノム編集技術産業の重要なプレーヤーになりつつあります。特に中国は、ゲノム編集に多額の投資と進歩が見られ、国を世界的な研究と応用の最前線に押し上げました。BGI GenomicsやHuada Genomics Instituteなどの機関は、CRISPR-Cas9技術の取り組みをリードし、人間の健康におけるブレークスルーと農業における大きな進歩を達成しています。これらの進歩は、食料安全保障や持続可能性などの重要な問題に対処し、中国市場におけるライフサイエンス研究に大きな長期的な成長機会を提供します。2023年の同国の研究開発費は前年比8.1%増の4,585億ドルを超え、高齢化による健康需要の高まりを反映しています。

インドとブラジルでもゲノム編集技術の進歩には目覚ましいものがあります。膨大な人口を抱え、バイオテクノロジー部門が急成長しているインドには、Rasi SeedsやMedGenomeなどの企業が作物改良と個別化医療の研究を先導しています。このように医療と農業に重点を置くことは、ゲノム編集を社会の利益のために活用するというインドのコミットメントを浮き彫りにしています。同様に、ブラジルは、医療と農業の課題に対処するためのゲノム編集の可能性を認識しています。Embrapaのような機関やRecepta Biopharmaのような企業は、国のニーズに合わせた新しい治療法や作物品種を積極的に開発し、精密医療と農業生産性の進歩を推進しています。これらの取り組みにより、ブラジルは世界のゲノム編集環境における重要なプレーヤーとして位置付けられています。

レポート詳細

目次

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Genome Editing Technologies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Number of Genomic Projects Coupled with the Government Funding
3.2.1.2 Rising Adoption of Genome Editing Technologies
3.2.1.3 Rising Burden of Chronic Diseases
3.2.1.4 Increasing Applications of Genomics for Medicine, Agriculture, and Biotechnology
3.2.2 Market Restraining Factors
3.2.2.1 Off-target Effects of CRISPR Technology
3.2.2.2 High Cost of Genome Editing Technologies
3.2.2.3 Regulatory Hurdles for Genome Editing Technology Application
3.2.3 Market Opportunities
3.2.3.1 Rising Demand for Genome Editing Technology in Emerging Economies
3.2.3.2 Strong Product Pipeline with Genome Editing Technology
3.2.3.3 Collaboration and Partnerships among Genome Editing Technologies Companies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Genome Editing Technologies Market Analysis by Technology
4.1 Key Findings
4.2 Technology Segment: Market Attractiveness Index
4.3 Genome Editing Technologies Market Size Estimation and Forecast by Technology
4.4 CRISPR
4.4.1 Market Size by Region, 2024-2034 (US$ Million)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 TALEN
4.5.1 Market Size by Region, 2024-2034 (US$ Million)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 ZFN
4.6.1 Market Size by Region, 2024-2034 (US$ Million)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Meganucleases
4.7.1 Market Size by Region, 2024-2034 (US$ Million)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Others
4.8.1 Market Size by Region, 2024-2034 (US$ Million)
4.8.2 Market Share by Region, 2024 & 2034 (%)

5 Genome Editing Technologies Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Genome Editing Technologies Market Size Estimation and Forecast by Application
5.4 Genetic Engineering
5.4.1 Market Size Estimation and Forecast by Type
5.4.2 Market Size by Region, 2024-2034 (US$ Million)
5.4.3 Market Share by Region, 2024 & 2034 (%)
5.4.4 Cell Line Engineering
5.4.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.4.2 Market Share by Region, 2024 & 2034 (%)
5.4.5 Animal Genetic Engineering
5.4.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.5.2 Market Share by Region, 2024 & 2034 (%)
5.4.6 Plant Genetic Engineering
5.4.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.6.2 Market Share by Region, 2024 & 2034 (%)
5.4.7 Others
5.4.7.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.7.2 Market Share by Region, 2024 & 2034 (%)
5.5 Drug Discovery & Development
5.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Diagnostic Applications
5.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Genome Editing Technologies Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Genome Editing Technologies Market Size Estimation and Forecast by End-users
6.4 Biotechnology Companies
6.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Pharmaceutical Companies
6.5.1 Market Size by Region, 2024-2034 (US$ Million)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Academic & Government Research Institutes
6.6.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Other End-users
6.7.1 Market Size by Region, 2024-2034 (US$ Million)
6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Genome Editing Technologies Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast

8 North America Genome Editing Technologies Market Analysis
8.1 Key Findings
8.2 North America Genome Editing Technologies Market Attractiveness Index
8.3 North America Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
8.4 North America Genome Editing Technologies Market Size Estimation and Forecast by Country
8.5 North America Genome Editing Technologies Market Size Estimation and Forecast by Technology
8.6 North America Genome Editing Technologies Market Size Estimation and Forecast by Application
8.6.1 North America Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
8.7 North America Genome Editing Technologies Market Size Estimation and Forecast by End-users
8.8 U.S. Genome Editing Technologies Market Analysis
8.9 Canada Genome Editing Technologies Market Analysis

9 Europe Genome Editing Technologies Market Analysis
9.1 Key Findings
9.2 Europe Genome Editing Technologies Market Attractiveness Index
9.3 Europe Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
9.4 Europe Genome Editing Technologies Market Size Estimation and Forecast by Country
9.5 Europe Genome Editing Technologies Market Size Estimation and Forecast by Technology
9.6 Europe Genome Editing Technologies Market Size Estimation and Forecast by Application
9.6.1 Europe Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
9.7 Europe Genome Editing Technologies Market Size Estimation and Forecast by End-users
9.8 Germany Genome Editing Technologies Market Analysis
9.9 UK Genome Editing Technologies Market Analysis
9.10 France Genome Editing Technologies Market Analysis
9.11 Italy Genome Editing Technologies Market Analysis
9.12 Spain Genome Editing Technologies Market Analysis
9.13 Russia Genome Editing Technologies Market Analysis
9.14 Rest of Europe Genome Editing Technologies Market Analysis

10 Asia Genome Editing Technologies Market Analysis
10.1 Key Findings
10.2 Asia Genome Editing Technologies Market Attractiveness Index
10.3 Asia Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
10.4 Asia Genome Editing Technologies Market Size Estimation and Forecast by Country
10.5 Asia Pacific Genome Editing Technologies Market Size Estimation and Forecast by Technology
10.6 Asia Pacific Genome Editing Technologies Market Size Estimation and Forecast by Application
10.6.1 Asia Pacific Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
10.7 Asia Pacific Genome Editing Technologies Market Size Estimation and Forecast by End-users
10.8 Japan Genome Editing Technologies Market Analysis
10.9 China Genome Editing Technologies Market Analysis
10.10 India Genome Editing Technologies Market Analysis
10.11 Australia Genome Editing Technologies Market Analysis
10.12 South Korea Genome Editing Technologies Market Analysis
10.13 Rest of Asia Genome Editing Technologies Market Analysis

11 Latin America Genome Editing Technologies Market Analysis
11.1 Key Findings
11.2 Latin America Genome Editing Technologies Market Attractiveness Index
11.3 Latin America Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
11.4 Latin America Genome Editing Technologies Market Size Estimation and Forecast by Country
11.5 Latin America Genome Editing Technologies Market Size Estimation and Forecast by Technology
11.6 Latin America Genome Editing Technologies Market Size Estimation and Forecast by Application
11.6.1 Latin America Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
11.7 Latin America Genome Editing Technologies Market Size Estimation and Forecast by End-users
11.8 Brazil Genome Editing Technologies Market Analysis
11.9 Mexico Genome Editing Technologies Market Analysis
11.10 Argentina Genome Editing Technologies Market Analysis
11.11 Rest of Latin America Genome Editing Technologies Market Analysis

12 MEA Genome Editing Technologies Market Analysis
12.1 Key Findings
12.2 MEA Genome Editing Technologies Market Attractiveness Index
12.3 MEA Genome Editing Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
12.4 MEA Genome Editing Technologies Market Size Estimation and Forecast by Country
12.5 MEA Genome Editing Technologies Market Size Estimation and Forecast by Technology
12.6 MEA Genome Editing Technologies Market Size Estimation and Forecast by Application
12.6.1 MEA Genome Editing Technologies Market Size Estimation and Forecast by Genetic Engineering
12.7 MEA Genome Editing Technologies Market Size Estimation and Forecast by End-users
12.8 GCC Genome Editing Technologies Market Analysis
12.9 South Africa Genome Editing Technologies Market Analysis
12.10 Rest of MEA Genome Editing Technologies Market Analysis

13 Company Profiles
13.1 Competitive Landscape, 2023
13.2 Strategic Outlook
13.3 Thermo Fisher Scientific Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2018-2023
13.3.3.2 R&D, 2018-2023
13.3.3.3 Regional Market Shares, 2023
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Lonza
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2018-2023
13.4.3.2 R&D, 2018-2023
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 CRISPR Therapeutics
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2018-2023
13.5.3.2 R&D, 2018-2023
13.5.4 Product Benchmarking
13.5.5 Strategic Outlook
13.6 Editas Medicine
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2018-2023
13.6.3.2 R&D, 2018-2023
13.6.4 Product Benchmarking
13.6.5 Strategic Outlook
13.7 Revvity
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2018-2023
13.7.3.2 R&D, 2018-2023
13.7.3.3 Regional Market Shares, 2023
13.7.4 Product Benchmarking
13.7.5 Strategic Outlook
13.8 Agilent Technologies
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2018-2023
13.8.3.2 R&D, 2018-2023
13.8.3.3 Regional Market Shares, 2023
13.8.4 Product Benchmarking
13.8.5 Strategic Outlook
13.9 GenScript
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2018-2023
13.9.3.2 R&D, 2018-2023
13.9.4 Product Benchmarking
13.9.5 Strategic Outlook
13.10 Merck KGaA
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2018-2023
13.10.3.2 R&D, 2018-2023
13.10.3.3 Regional Market Shares, 2023
13.10.4 Product Benchmarking
13.10.5 Strategic Outlook
13.11 Sangamo Therapeutics
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2018-2023
13.11.3.2 R&D, 2018-2023
13.11.4 Product Benchmarking
13.11.5 Strategic Outlook
13.12 Precision Biosciences
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2018-2023
13.12.3.2 R&D, 2018-2023
13.12.4 Product Benchmarking
13.12.5 Strategic Outlook
13.13 Tecan Trading AG
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2018-2023
13.13.3.2 R&D, 2018-2023
13.13.3.3 Regional Market Shares, 2023
13.13.4 Product Benchmarking
13.13.5 Strategic Outlook
13.14 Takara Bio Inc.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2018-2023
13.14.4 Product Benchmarking
13.14.5 Strategic Outlook
13.15 Danaher Corporation
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2018-2023
13.15.3.2 R&D, 2018-2023
13.15.3.3 Regional Market Shares, 2023
13.15.4 Product Benchmarking
13.15.5 Strategic Outlook
13.16 Recombinetics
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Product Benchmarking
13.17 Intellia Therapeutics Inc.
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2018-2023
13.17.3.2 R&D, 2018-2023
13.17.4 Product Benchmarking
13.17.5 Strategic Outlook
13.18 Cellectis
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Financial Analysis
13.18.3.1 Net Revenue, 2018-2023
13.18.3.2 R&D, 2018-2023
13.18.3.3 Regional Market Shares, 2023
13.18.4 Product Benchmarking
13.18.5 Strategic Outlook
13.19 Cibus Inc.
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Financial Analysis
13.19.3.1 Net Revenue, 2018-2023
13.19.3.2 R&D, 2018-2023
13.19.4 Product Benchmarking
13.19.5 Strategic Outlook
13.20 Caribou Biosciences, Inc.
13.20.1 Company Snapshot
13.20.2 Company Overview
13.20.3 Financial Analysis
13.20.3.1 Net Revenue, 2019-2023
13.20.3.2 R&D, 2019-2023
13.20.3.3 Regional Market Shares, 2023
13.20.4 Product Benchmarking

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

List of Tables
Table 1 Genome Editing Technologies Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
Table 2 Worldwide Chronic Diseases Incidence, 2023 (Million)
Table 3 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 4 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 5 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 6 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 7 Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 8 CRISPR Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 9 TALEN Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 10 ZFN Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 11 Meganucleases Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 12 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 13 Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 14 Genetic Engineering Segment Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 15 Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 16 Cell Line Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 17 Animal Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 18 Plant Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 20 Drug Discovery & Development Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 21 Diagnostic Applications Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 22 Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 23 Biotechnology companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 24 Pharmaceutical Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 25 Academic & Government Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 26 Other End-users Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 27 Genome Editing Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 28 North America Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 29 North America Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 30 North America Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 31 North America Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 32 North America Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 33 U.S. Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 34 Canada Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 35 Europe Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 36 Europe Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 37 Europe Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 38 Europe Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 39 Europe Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 40 Germany Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 41 UK Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 42 France Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 43 Italy Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 44 Spain Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 45 Russia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 46 Rest of Europe Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 47 Asia Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 52 Japan Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 53 China Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 54 India Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 55 Australia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 56 South Korea Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 57 Rest of Asia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 58 Latin America Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 59 Latin America Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 60 Latin America Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 61 Latin America Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 63 Brazil Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 64 Mexico Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 65 Argentina Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 66 Rest of Latin America Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 67 MEA Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 68 MEA Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 69 MEA Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 70 MEA Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 71 MEA Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 72 GCC Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 73 South Africa Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 74 Rest of MEA Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 75 Strategic Outlook
Table 76 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 78 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 79 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Lonza: Product Benchmarking
Table 81 Lonza: Strategic Outlook
Table 82 CRISPR Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 CRISPR Therapeutics: Product Benchmarking
Table 84 CRISPR Therapeutics: Strategic Outlook
Table 85 Editas Medicine: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Editas Medicine: Product Benchmarking
Table 87 Editas Medicine: Strategic Outlook
Table 88 Revvity: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Revvity: Product Benchmarking
Table 90 Revvity: Strategic Outlook
Table 91 Agilent Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Agilent Technologies: Product Benchmarking
Table 93 Agilent Technologies: Strategic Outlook
Table 94 GenScript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 GenScript: Product Benchmarking
Table 96 GenScript: Strategic Outlook
Table 97 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Merck KGaA: Product Benchmarking
Table 99 Merck KGaA: Strategic Outlook
Table 100 Sangamo Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Sangamo Therapeutics: Product Benchmarking
Table 102 Sangamo Therapeutics: Strategic Outlook
Table 103 Precision Biosciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Precision Biosciences: Product Benchmarking
Table 105 Precision Biosciences: Strategic Outlook
Table 106 Tecan Trading AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Tecan Trading AG: Product Benchmarking
Table 108 Tecan Trading AG: Strategic Outlook
Table 109 Takara Bio Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Takara Bio Inc.: Product Benchmarking
Table 111 Takara Bio Inc.: Strategic Outlook
Table 112 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Danaher Corporation: Product Benchmarking
Table 114 Danaher Corporation: Strategic Outlook
Table 115 Recombinetics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Recombinetics: Product Benchmarking
Table 117 Intellia Therapeutics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Intellia Therapeutics Inc.: Product Benchmarking
Table 119 Intellia Therapeutics Inc.: Strategic Outlook
Table 120 Cellectis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Cellectis: Product Benchmarking
Table 122 Cellectis: Strategic Outlook
Table 123 Cibus Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Cibus Inc.: Product Benchmarking
Table 125 Cibus Inc.: Strategic Outlook
Table 126 Caribou Biosciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Caribou Biosciences, Inc.: Product Benchmarking
?

List of Figures
Figure 1 Genome Editing Technologies Market Segmentation
Figure 2 Genome Editing Technologies Market by Technology: Market Attractiveness Index
Figure 3 Genome Editing Technologies Market by Application: Market Attractiveness Index
Figure 4 Genome Editing Technologies Market by End-users: Market Attractiveness Index
Figure 5 Genome Editing Technologies Market Attractiveness Index by Region
Figure 6 Genome Editing Technologies Market: Market Dynamics
Figure 7 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %): “V” Shaped Recovery
Figure 8 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %): “U” Shaped Recovery
Figure 9 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %): “W” Shaped Recovery
Figure 10 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %): “L” Shaped Recovery
Figure 11 Genome Editing Technologies Market: Porter’s Five Forces Analysis
Figure 12 Genome Editing Technologies Market: PEST Analysis
Figure 13 Genome Editing Technologies Market by Technology: Market Attractiveness Index
Figure 14 Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
Figure 15 Genome Editing Technologies Share Forecast by Technology, 2024, 2029, 2034 (%)
Figure 16 CRISPR Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 17 CRISPR Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 18 TALEN Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 19 TALEN Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 ZFN Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 21 ZFN Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Meganucleases Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 23 Meganucleases Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 25 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Genome Editing Technologies Market by Application: Market Attractiveness Index
Figure 27 Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 28 Genome Editing Technologies Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 29 Genetic Engineering Segment Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 30 Genetic Engineering Segment Market Forecast by Type, 2024, 2029, 2034 (%)
Figure 31 Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 32 Genetic Engineering Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 33 Cell Line Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 34 Cell Line Engineering Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 35 Animal Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 36 Animal Genetic Engineering Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Plant Genetic Engineering Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 38 Plant Genetic Engineering Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 40 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Drug Discovery & Development Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 42 Drug Discovery & Development Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Diagnostic Applications Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 44 Diagnostic Applications Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Genome Editing Technologies Market by End-users: Market Attractiveness Index
Figure 46 Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 47 Genome Editing Technologies Share Forecast by End-users, 2024, 2029, 2034 (%)
Figure 48 Biotechnology companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 49 Biotechnology companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Pharmaceutical Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 51 Pharmaceutical Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Academic & Government Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 53 Academic & Government Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Other End-users Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 55 Other End-users Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 56 Genome Editing Technologies Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 57 Genome Editing Technologies Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 58 Genome Editing Technologies Market by Region, 2024-2034 (US$ Million, AGR %)
Figure 59 North America Genome Editing Technologies Market Attractiveness Index
Figure 60 North America Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 61 North America Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 62 North America Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 63 North America Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
Figure 64 North America Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
Figure 65 North America Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 66 North America Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 67 North America Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
Figure 68 North America Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
Figure 69 North America Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 70 North America Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 71 U.S. Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 72 Canada Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 73 Europe Genome Editing Technologies Market Attractiveness Index
Figure 74 Europe Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 75 Europe Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 76 Europe Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 77 Europe Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
Figure 78 Europe Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
Figure 79 Europe Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 80 Europe Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 81 Europe Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
Figure 82 Europe Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
Figure 83 Europe Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 84 Europe Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 85 Germany Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 86 UK Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 87 France Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 88 Italy Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 89 Spain Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 90 Russia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 91 Rest of Europe Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 92 Asia Genome Editing Technologies Market Attractiveness Index
Figure 93 Asia Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 94 Asia Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 95 Asia Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 96 Asia Pacific Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
Figure 97 Asia Pacific Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
Figure 98 Asia Pacific Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 99 Asia Pacific Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 100 Asia Pacific Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
Figure 101 Asia Pacific Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
Figure 102 Asia Pacific Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 103 Asia Pacific Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 104 Japan Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 105 China Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 106 India Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 107 Australia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 108 South Korea Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 109 Rest of Asia Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 110 Latin America Genome Editing Technologies Market Attractiveness Index
Figure 111 Latin America Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 112 Latin America Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 113 Latin America Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 114 Latin America Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
Figure 115 Latin America Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
Figure 116 Latin America Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 117 Latin America Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 118 Latin America Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
Figure 119 Latin America Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
Figure 120 Latin America Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 121 Latin America Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 122 Brazil Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 123 Mexico Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 124 Argentina Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 125 Rest of Latin America Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 126 MEA Genome Editing Technologies Market Attractiveness Index
Figure 127 MEA Genome Editing Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 128 MEA Genome Editing Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 129 MEA Genome Editing Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 130 MEA Genome Editing Technologies Market Forecast by Technology, 2024-2034 (US$ Million, AGR %)
Figure 131 MEA Genome Editing Technologies Market Share Forecast by Technology, 2024 & 2034 (%)
Figure 132 MEA Genome Editing Technologies Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 133 MEA Genome Editing Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 134 MEA Genome Editing Technologies Market Forecast by Genetic Engineering, 2024-2034 (US$ Million, AGR %)
Figure 135 MEA Genome Editing Technologies Market Share Forecast by Genetic Engineering, 2024 & 2034 (%)
Figure 136 MEA Genome Editing Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 137 MEA Genome Editing Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 138 GCC Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 139 South Africa Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 140 Rest of MEA Genome Editing Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 141 Clinical Trial Supplies Market: Company Share, 2023
Figure 142 Thermo Fisher Scientific Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 143 Thermo Fisher Scientific Inc.: R&D, 2018-2023 (US$ Million, AGR%)
Figure 144 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2023
Figure 145 Lonza: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 146 Lonza: R&D, 2018-2023 (US$ Million, AGR%)
Figure 147 CRISPR Therapeutics: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 148 CRISPR Therapeutics: R&D, 2018-2023 (US$ Million, AGR%)
Figure 149 Editas Medicine: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 150 Editas Medicine: R&D, 2018-2023 (US$ Million, AGR%)
Figure 151 Revvity: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 152 Revvity: R&D, 2018-2023 (US$ Million, AGR%)
Figure 153 Revvity: Regional Market Shares (%), 2023
Figure 154 Agilent Technologies: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 155 Agilent Technologies: R&D, 2018-2023 (US$ Million, AGR%)
Figure 156 Agilent Technologies: Regional Market Shares (%), 2023
Figure 157 GenScript: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 158 GenScript: R&D, 2018-2023 (US$ Million, AGR%)
Figure 159 Merck KGaA: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 160 Merck KGaA: R&D, 2018-2023 (US$ Million, AGR%)
Figure 161 Merck KGaA: Regional Market Shares (%), 2023
Figure 162 Sangamo Therapeutics: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 163 Sangamo Therapeutics: R&D, 2018-2023 (US$ Million, AGR%)
Figure 164 Precision Biosciences: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 165 Precision Biosciences: R&D, 2018-2023 (US$ Million, AGR%)
Figure 166 Tecan Trading AG: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 167 Tecan Trading AG: R&D, 2018-2023 (US$ Million, AGR%)
Figure 168 Tecan Trading AG: Regional Market Shares (%), 2023
Figure 169 Takara Bio Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 170 Danaher Corporation: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 171 Danaher Corporation: R&D, 2018-2023 (US$ Million, AGR%)
Figure 172 Danaher Corporation: Regional Market Shares (%), 2023
Figure 173 Intellia Therapeutics Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 174 Intellia Therapeutics Inc.: R&D, 2018-2023 (US$ Million, AGR%)
Figure 175 Cellectis: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 176 Cellectis: R&D, 2018-2023 (US$ Million, AGR%)
Figure 177 Cellectis: Regional Market Shares (%), 2023
Figure 178 Cibus Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 179 Cibus Inc.: R&D, 2018-2023 (US$ Million, AGR%)
Figure 180 Caribou Biosciences, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR%)
Figure 181 Caribou Biosciences, Inc.: R&D, 2019-2023 (US$ Million, AGR%)
Figure 182 Caribou Biosciences, Inc.: Regional Market Shares (%), 2023

この商品のレポートナンバー

0000038545

TOP